Comparative Temperature Analysis
Temperature Trends
Distribution Comparison
Ruxolitinib Effect (Patient 1)
Early Warning Model
| Patient | Target | Lag (days) | Spearman rho | p-value | n | Significant |
|---|---|---|---|---|---|---|
| P2 | Readiness Score | 0 | -0.082 | p=0.084 | 449 | No |
| P2 | Readiness Score | 1 | -0.060 | p=0.205 | 448 | No |
| P2 | Readiness Score | 2 | -0.039 | p=0.414 | 447 | No |
| P2 | Average HR | 0 | 0.081 | p=0.087 | 448 | No |
| P2 | Average HR | 1 | 0.039 | p=0.412 | 447 | No |
| P2 | Average HR | 2 | 0.060 | p=0.203 | 446 | No |
| P3 | Readiness Score | 0 | nan | N/A | 22 | No |
| P3 | Readiness Score | 1 | nan | N/A | 21 | No |
| P3 | Readiness Score | 2 | nan | N/A | 20 | No |
| P3 | Average HR | 0 | nan | N/A | 22 | No |
| P3 | Average HR | 1 | nan | N/A | 21 | No |
| P3 | Average HR | 2 | nan | N/A | 20 | No |
Temperature Calendar Heatmap
Known Events Validation
| Patient | Date | Event | Expected | Actual | Validated |
|---|---|---|---|---|---|
| P2 | 2022-05-04 | +13C flight day | 13.0 | 13.00 C | Yes |
| P1 | 2026-02-09 | Acute event (Feb 9) | None | No data | No |
Top Temperature Spikes (> +1.0 C)
| Patient | Date | Temp Delta | Classification |
|---|---|---|---|
| P2 | 2022-05-04 | +13.00 C | Fever |
Clinical Interpretation
- Anomalies: 1 total anomaly days detected (Patient 1: 0, Patient 2: 1) using 2-SD threshold.
Methodology
Data Source: Oura Ring sleep temperature deviation (temperature_delta) measures nightly skin temperature relative to the wearer's personal baseline, in degrees Celsius. Also incorporates readiness temperature_deviation.
Anomaly Detection: Days where |temperature_delta| exceeds 2 standard deviations from the patient's own mean are flagged as anomalies.
Classification: Fever (>+1.0 C), mild elevation (+0.5 to +1.0 C), normal (-0.5 to +0.5 C), mild low (-1.0 to -0.5 C), hypothermia (<-1.0 C).
Early Warning Model: Spearman rank correlations at lags 0, 1, and 2 days test whether temperature deviations predict changes in readiness score or heart rate 1-2 days later.
Treatment Analysis: Pre/post Ruxolitinib comparison uses Mann-Whitney U on |temperature_delta| and Levene's test for variance equality.
Cross-patient Comparison: Mann-Whitney U test with Cohen's d effect size and 95% bootstrap confidence intervals (10,000 iterations).